Clinical trial
PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
NCT00269620 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00269620 |
|---|---|
| Title | PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra |
| Official title | An Open-Label, Randomized, Multicenter Trial to Evaluate Continuation Rates, Side Effects and Acceptability of NuvaRing Versus OrthoEvra |
| Acronym | PARIS |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Organon Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | ethinyl estradiol/etonogestrel vaginal ring, ethinyl estradiol/norelgestromin transdermal contraceptive |
| Enrollment | 500 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Dec 23, 2005 |
| Last update posted | Oct 21, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: